SenesTech (NASDAQ:SNES) Earns Sell Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of SenesTech (NASDAQ:SNESFree Report) in a research note released on Friday. The firm issued a sell rating on the stock.

Separately, HC Wainwright restated a buy rating and issued a $3.50 target price on shares of SenesTech in a report on Tuesday, May 14th.

Read Our Latest Research Report on SNES

SenesTech Price Performance

Shares of NASDAQ SNES opened at $0.60 on Friday. The company has a debt-to-equity ratio of 0.03, a quick ratio of 5.69 and a current ratio of 6.91. The stock’s fifty day simple moving average is $0.67 and its 200 day simple moving average is $0.82. SenesTech has a 52-week low of $0.49 and a 52-week high of $12.36.

SenesTech (NASDAQ:SNESGet Free Report) last issued its earnings results on Thursday, May 9th. The company reported ($0.36) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.34) by ($0.02). The company had revenue of $0.42 million during the quarter, compared to analyst estimates of $0.43 million. SenesTech had a negative return on equity of 181.46% and a negative net margin of 545.82%. During the same quarter in the previous year, the firm earned ($15.85) earnings per share. As a group, sell-side analysts predict that SenesTech will post -1.1 earnings per share for the current year.

Institutional Trading of SenesTech

A hedge fund recently bought a new stake in SenesTech stock. McAdam LLC bought a new position in SenesTech, Inc. (NASDAQ:SNESFree Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 64,348 shares of the company’s stock, valued at approximately $44,000. McAdam LLC owned 1.25% of SenesTech as of its most recent SEC filing. Hedge funds and other institutional investors own 5.19% of the company’s stock.

About SenesTech

(Get Free Report)

SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.

Further Reading

Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.